Patent US4470987A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4470987A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for treatment and prevention of ventricular fibrillation

Assignee: Massachusetts Institute of Technology
•
Filing: 1981-05-18
•
Granted: 1984-09-11
•
Expires: 2001-05-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The risk of ventricular fibrillation in animals is reduced by administering tyrosine, a tyrosine precursor, threonine or mixtures thereof, either alone or in combination with a substance which is known to reduce the risk of ventricular fibrillation. A novel composition is provided comprising a unit dosage form of tyrosine, a precursor for tyrosine, threonine or mixtures thereof and a substance which is known to reduce the risk of ventricular fibrillation.

Inventors

  • 👤 Richard J. Wurtman
  • 👤 Bernard Lown

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 21:20
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19; A61K31/195

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 90 words
The process for preventing or treating ventricular fibrillation in an animal having a condition associated with ventricular fibrillation which comprises administering to the animal a mixture of (a) a compound selected from the group consisting of tyrosine, phenylalanine, threonine or mixtures thereof and (b) a drug selected from the group consisting of procaine amide, quinidine, propranolol, disopyramide, or pharmaceutically acceptable salts thereof and mixtures thereof in an amount effective to prevent or treat ventricular fibrillation wherein the dosage of (a) is between about 0.5 and about 20 mg/kg body weight.
Claim 2
Dependent Claim 90 words
The process for preventing or treating ventricular fibrillation in an animal having a condition associated with ventricular fibrillation which comprises administering to the animal a mixture of (a) a compound selected from the group consisting of tyrosine, phenylalanine, threonine or mixtures thereof and (b) a drug selected from the group consisting of procaine amide, quinidine, propranolol, disopyramide, or pharmaceutically acceptable salts thereof and mixtures thereof in an amount effective to prevent or treat ventricular fibrillation wherein the dosage of (a) is between about 0.5 and about 20 mg/kg body weight.
Claim 3
Dependent Claim 11 words
The process of claim 1 wherein the animal is a human.
Claim 4
Dependent Claim 15 words
The process of any one of claims 1 or 2 wherein the compound is threonine.
Claim 5
Dependent Claim 15 words
The process of any one of claims 1 or 2 wherein the compound is tyrosine.
Claim 6
Dependent Claim 69 words
A composition comprising a mixture of (a) a compound selected from the group consisting of tyrosine, phenylalanine, threonine or mixtures thereof and (b) a drug selected from the group consisting of procaine amide, quinidine, propranolol, disopyramide or pharmaceutically acceptable salts thereof and mixtures thereof in an amount effective to prevent or treat ventricular fibrillation wherein the dosage of (a) is between about 0.5 and about 20 mg/kg body weight.
Claim 7
Dependent Claim 69 words
A composition comprising a mixture of (a) a compound selected from the group consisting of tyrosine, phenylalanine, threonine or mixtures thereof and (b) a drug selected from the group consisting of procaine amide, quinidine, propranolol, disopyramide or pharmaceutically acceptable salts thereof and mixtures thereof in an amount effective to prevent or treat ventricular fibrillation wherein the dosage of (a) is between about 0.5 and about 20 mg/kg body weight.
Claim 8
Dependent Claim 10 words
The composition of claim 5 wherein the compound is tyrosine.
Claim 9
Dependent Claim 10 words
The composition of claim 5 wherein the compound is threonine.

References Cited (Backward Citations)

US3651237A Cited
US4230719A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-09-11 1988-03-12 1988-09-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-09-11 1992-03-12 1992-09-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-09-11 1996-03-12 1996-09-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag